MAGED2: A Novel P53-Dissociator

International Journal of Oncology - Greece
doi 10.3892/ijo.31.5.1205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

28. Novel Fusion MAGED2-PLAG1 in Endometrial Stromal Sarcoma

Pathology
Forensic MedicinePathology
2020English

A Novel Mutant P53 Binding Partner BAG5 Stabilizes Mutant P53 and Promotes Mutant P53 GOFs in Tumorigenesis

Cell Discovery
BiochemistryGeneticsCell BiologyMolecular Biology
2016English

MicroRNA-125b Is a Novel Negative Regulator of P53

Genes and Development
GeneticsDevelopmental Biology
2009English

Identification of TRIML2, a Novel P53 Target, That Enhances P53 SUMOylation and Regulates the Transactivation of Proapoptotic Genes

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2014English

Novel Insights Into the Cytoplasmic Functions of P53

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

NCF2/p67phox: A Novel Player in the Anti-Apoptotic Functions of P53

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2013English

Novel Link Between E2F and P53: Proapoptotic Cofactors of P53 Are Transcriptionally Upregulated by E2F

Cell Death and Differentiation
Cell BiologyMolecular Biology
2005English

MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells

Oncotarget
Oncology
2016English

Pharmacological Activation of a Novel P53-Dependent S-Phase Checkpoint Involving CHK-1

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy